What is 32Co?
Founded in 2021 and headquartered in London, England, 32Co is at the forefront of collaborative healthcare, aiming to transform access to specialized medical services. The platform connects general clinicians with a network of specialists, drawing inspiration from the telemedicine sector. By facilitating seamless collaboration between generalist and specialist practitioners, 32Co ensures patients receive high-quality clinical care conveniently through their local providers. This innovative model effectively scales specialist expertise beyond the confines of a single clinic, leveraging a global network of generalist colleagues.
How much funding has 32Co raised?
32Co has raised a total of $2.7M across 1 funding round:
Other Financing Round
$2.7M
Other Financing Round (2023): $2.7M with participation from Balderton and Wavemaker Three-Sixty Health
Key Investors in 32Co
Balderton
Balderton Capital (balderton.com) is a London-based venture capital firm that focuses on early-stage, high-growth technology companies across Europe, typically leading Seed and Series A rounds and supporting founders through global scaleup and exits.
Wavemaker Three-Sixty Health
Wavemaker Three-Sixty Health is a leading U.S. venture capital fund that focuses exclusively on early-stage healthcare startups, investing in promising companies across North America. The firm is backed by Limited Partners with extensive experience in the healthcare industry, enabling it to identify and support transformative healthcare innovations.
What's next for 32Co?
The recent major strategic investment signals a pivotal growth phase for 32Co, likely enabling the company to further scale its operations, enhance its technological infrastructure, and expand its network of healthcare professionals. This capital infusion is expected to accelerate the company's mission to democratize access to specialized medical knowledge and services, solidifying its position as a key player in the digital health landscape.
See full 32Co company page
